BioSpace News Archive

Top-line results expected in second half of 2020

In 2017, a lawsuit was filed alleging that Eli Lilly and Bayer, as well as other companies, attempted to use the free nursing services as a way to boost sales of diabetes drugs, such as Humalog and Humulin, as well as other drugs.

The NOAA RESTORE Science Program has awarded approximately $15.6 million in grants to four teams of researchers and resource managers from across 20 institutions including universities, federal and state agencies and non-governmental organizations to support work on living coastal and marine resources and their habitats in the Gulf of Mexico.

PDS0101- KEYTRUDA® (pembrolizumab) Combination to be Evaluated in First Line Treatment of Metastatic Head and Neck Cancer

Under terms of the global royalty agreement, Q BioMed will assume immediate ownership of the pain asset, as well as an abbreviated new drug application for the treatment.

Life science and pharma companies strengthen their leadership teams with this week’s appointments.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Panel is the only direct-from-blood diagnostic designed to detect genetic markers associated with antibiotic-resistant bloodstream infections

Araris Biotech AG announced the appointment of Dr. Rakesh Dixit, Dr. John Lambert and Dr. L. Nathan Tumey as members of its Scientific Advisory Board.

Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting